Prosecution Insights
Last updated: April 19, 2026

UNIVERSITE DE MONTPELLIER

14 pending office actions

Portfolio Summary

14
Total Pending OAs
2
Final Rejections
12
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18716360 BUS DISTRIBUTED STIMULATION AND MEASUREMENT SYSTEM STICE, PAULA J 3796 Non-Final OA Jun 04, 2024
18697907 METHOD FOR ANALYSING A NOISY SOUND SIGNAL FOR THE RECOGNITION OF CONTROL KEYWORDS AND OF A SPEAKER OF THE ANALYSED NOISY SOUND SIGNAL COLUCCI, MICHAEL C 2655 Non-Final OA May 02, 2024
18293096 INTERLEAVED NEURAL STIMULATION GETZOW, SCOTT M 3792 Non-Final OA Jan 29, 2024
18575159 DEVICE FOR MEASURING DEFORMATIONS IN A BOREHOLE HA, NGUYEN Q 2853 Non-Final OA Dec 28, 2023
18563284 NOVEL AZAINDOLE DERIVATIVES AS ANTIVIRAL AGENTS OH, TAYLOR V 1625 Non-Final OA Nov 21, 2023
18278494 ALLELE-SPECIFIC GENOME EDITING OF THE NR2E3 MUTATION G56R POLIAKOVA-GEORGAN, EKATERINA 1637 Non-Final OA Aug 23, 2023
18546300 COMBINATION OF A SERCA2 INHIBITOR AND A STING ACTIVATOR FOR USE IN TREATING AND/OR PREVENTING CANCER DEKARSKE, MADELINE MCGUIRE 1622 Non-Final OA Aug 14, 2023
18275331 BILE SALTS BACTOSENSOR AND USE THEREOF FOR DIAGNOSITC AND THERAPEUTIC PURPOSES ARMATO JR, DENNIS IGNATIUS 1651 Non-Final OA Aug 01, 2023
18250018 C-TERMINAL SPARC FRAGMENTS FOR TREATING CANCER NICKOL, GARY B 1643 Non-Final OA Apr 21, 2023
18248240 NOVEL PEPTOIDS AND USE THEREOF FOR PREVENTING OR TREATING CHRONIC PAIN NIEBAUER, RONALD T 1658 Non-Final OA Apr 06, 2023
18041902 EUKARYOTIC DNA REPLICATION ORIGINS, AND VECTOR CONTAINING THE SAME LAFAVE, ELIZABETH ROSE 1684 Non-Final OA Feb 16, 2023
17756456 MESENCHYMAL STEM CELLS WITH ENHANCED THERAPEUTIC PROPERTIES PENNINGTON, KATIE LEIGH 1634 Final Rejection May 25, 2022
17631908 METHOD FOR SCREENING A SUBJECT FOR A CANCER SCHLOOP, ALLISON ELIZABETH 1683 Final Rejection Feb 01, 2022
17416988 BIOMARKERS, AND USES IN TREATMENT OF VIRAL INFECTIONS, INFLAMMATIONS, OR CANCER SITTON, JEHANNE SOUAYA 1682 Non-Final OA Jun 21, 2021

Managing UNIVERSITE DE MONTPELLIER's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month